Key result
Functioning adrenal tumors linked to AAD, with ~55% stopping antihypertensives after tumor removal.
Why the study?
Arterial hypertension is a major modifiable risk factor for acute aortic dissection, but endocrine causes of secondary hypertension are rarely reported in association with adrenal disease.
Are functional adrenal tumors associated with acute aortic dissection and does their removal improve hypertension?
Systematic Review (n=23)
Are functional adrenal tumors associated with acute aortic dissection and does their removal improve hypertension?
Adrenal hormone-producing tumors are a clinically significant cause of secondary hypertension that can trigger acute aortic dissection, and their removal often allows suspension of antihypertensive therapy.
Answers are grounded in this paper and cite their sources.
Supports adrenal tumor evaluation in hypertensive aortic dissection; extends observational links to secondary hypertension.
Background Acute aortic dissection (AAD) is a life-threatening vascular emergency. While arterial hypertension is the most significant modifiable risk factor for AAD, endocrine causes of secondary hypertension are rarely reported in association with adrenal disease. We investigated the pathophysiological link between functioning adrenal tumors and AAD. Methods A systematic literature search was conducted using Scopus, Embase, and Medline from 1966 to June 2025. Inclusion criteria consisted of patients affected by AAD and pheochromocytoma, primary aldosteronism, Cushing’s syndrome, and adrenal oncocytoma. We also included a 49-year-old man who presented at our institution with Stanford type A dissection and an incidental left adrenal mass, subsequently diagnosed as pheochromocytoma. Results Twenty-three cases met the inclusion criteria, including our case. The mean age was 46.0 ± 10.7 years (range: 30–65 years). Hypertension was present in 91% of cases, often requiring multiple antihypertensive medications. Functioning adrenal tumors included primary aldosteronism (50%), pheochromocytoma (32%), Cushing’s syndrome (14%), and adrenal oncocytoma (4%). Mean follow-up was 7.5 ± 3.4 months. Eleven patients (55%) suspended the antihypertensive therapy following adrenal tumor removal. Conclusion : Adrenal hormone-producing tumors are an often overlooked but clinically significant cause of secondary hypertension and should be considered as potentially associated with AAD. Early detection and targeted treatment of adrenal disorders may help prevent these life-threatening complications.
No takes yet. Share an insight, caveat, or question.
Cicioni et al. (2026) conducted a systematic review in Acute aortic dissection and functioning adrenal tumors (n=23). Functioning adrenal tumors was evaluated on Presence of hypertension. Functioning adrenal tumors are associated with acute aortic dissection, with 91% of cases presenting with hypertension and 55% suspending antihypertensive therapy after tumor removal.
Synapse has enriched 10 related papers. Consider them for comparative context: